NCT03828773 2025-12-09
PTX3AML
Centre Hospitalier Universitaire Vaudois
Phase NA Recruiting
Clinical Trials
12 trialsNCT06510699 2025-11-19
PRAGMATIC
The University of Queensland
Phase 2 Recruiting
NCT06582186 2024-09-03
VORIPRECI
University Hospital, Grenoble
Phase 4 Not yet recruiting
NCT00896493 2023-05-11
Ph II of Non-myeloablative Allogeneic Transplantation Using TLI & ATG In Patients w/ Cutaneous T Cell Lymphoma
Stanford University
Phase 2 Completed
NCT03434704 2022-07-19
SIR-POSA
IRCCS San Raffaele
Phase 2 Completed
NCT02358499 2020-12-22
Genetic Variation and Variability in Posaconazole Pharmacokinetics in Children
Children's Mercy Hospital Kansas City
Phase 1 Completed
NCT03159364 2019-09-19
Antigen-specific Cytotoxic T Cells in the Treatment of Opportunistic Infections
Shenzhen Geno-Immune Medical Institute
Phase 1/2 Unknown
NCT01615809 2018-03-29
Nebulized Amphotericin B Lipid Complex in Invasive Pulmonary Aspergillosis in Paediatric Patients With Acute Leukaemia
Fundació Sant Joan de Déu
Phase 2 Completed
NCT01416025 2016-08-18
VoriTDM
Johns Hopkins University
Phase 4 Completed
NCT00904995 2012-08-07
Beta Glucan Assay in Patients Receiving Voriconazole Prophylaxis
M.D. Anderson Cancer Center
Phase 3 Completed
NCT00501098 2009-09-22
PROFIL-C
Northern Italy Leukemia Group
Phase 2 Completed
NCT00336531 2008-11-19
Efficacy of Prophylactic Itraconazole in High-Dose Chemotherapy and Autologous Hematopoietic Stem Cell Transplantation
Samsung Medical Center
Phase 4 Completed